📰 Sameera Shah News
Sameera Shah News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sameera Shah. Real-time updates on events, politics, business and more.
May 22, 2024
The Street was most impressed with Metropolis Health ability to expand its EBITDA margin in Q4FY24 despite embarking on network expansion.
May 22, 2024
This resurgence is expected to be fuelled by increased testing, strategic price adjustments, expansion of wellness services, says report by HDFC Securities
May 22, 2024
Metropolis Healthcare Limited will look for acquisitions. Ameera Shah, Managing Director said, We intend to evaluate such targets nationwide and do multiple bolt-on acquisitions that will create...
May 22, 2024
Metropolis Healthcare transitions to promoter-led, professionally managed firm with Ameera Shah as Executive Chairperson and Whole Time Director.
May 21, 2024
The diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 11% YoY to Rs 313 crore.
April 6, 2024
From reading stories of Noor Jehan and Elizabeth I to writing a rom com, this writer talks about her latest book on Indian women bosses
April 5, 2024
A tenet on turning ten. As ETPanache toasts its 10th anniversary, corporate bosses share why laughter, learning and loving the job are some of their top commandments
February 2, 2024
"The performance in Q3 was marginally impacted on account of heavy rainfall and floods in Chennai and adjacent areas in December 2023, leading to loss of revenues for approx. 7-8 days from Chennai region, which is one of the focus cities for Metropolis," Ameera Shah, promoter and managing director of Metropolis Healthcare said.
January 15, 2024
Experts suggest that it presents an opportunity to address this gap, potentially increasing healthcare allocation to 2.5% of GDP from 1.6% at present, as recommended by the NITI Aayog
January 14, 2024
In the upcoming union budget 2024, the Indian pharmaceutical industry is seeking fiscal incentives to promote research and development (R&D) as it is expected to reach a market size of USD 400-450 billion by 2047. The Indian Pharmaceutical Alliance Secretary General, Sudarshan Jain, emphasized the need for continuous investments in research due to high risk and low success rates. The interim Budget 2024-25 should provide benefits in terms of direct and indirect taxes and facilitate business ...